Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse SOCS2 ELISA Kit (AC3934)
Cat.#: ASET-2523
Specifications
Description Mouse SOCS2 ELISA Kit allows for the in vitro quantitative determination of mouse SOCS2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2244 Human Big Dynorphin ELISA Kit (AC3655) Quantitative inquiry ASET-1641 Human LRRK2 ELISA Kit (AC3052) Quantitative inquiry ASET-1675 Mouse Reelin ELISA Kit (AC3086) Quantitative inquiry ASET-1446 Human Semaphorin 7a ELISA Kit (AC2857) Quantitative inquiry ASET-1211 Goat IL-6 ELISA Kit (AC2622) Quantitative inquiry ASET-1414 Mouse beta 1 Adrenergic Receptor ELISA Kit (AC2825) Quantitative inquiry ASET-1057 Human COMT ELISA Kit (AC2468) Quantitative inquiry ASET-2410 Human NDRG1 ELISA Kit (AC3821) Quantitative inquiry ASET-1382 Monkey Apolipoprotein E ELISA Kit (AC2793) Quantitative inquiry ASET-1167 Rat NRG1 ELISA Kit (AC2578) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket